> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guidance on Prescription-use Glucose Monitors
- URL: https://www.fdaweb.com/guidance-on-prescription-use-glucose-monitors/
- Published: 2016-10-11T12:00:00.000Z
- Updated: 2026-09-14T21:38:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137055

*Federal Register* Notice: FDA has made available a guidance entitled “Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use.” The document describes studies and criteria that FDA recommends be used when submitting premarket notifications (510(k)s) for blood glucose monitoring systems which are for prescription point-of-care use in professional healthcare settings. To view the guidance, click [here](http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM380325.pdf?ref=fdaweb.com). To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-10-11/pdf/2016-24430.pdf?ref=fdaweb.com).